Hawm Parenteral Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth -160.93%
- Ebitda -118.22%
- Net Worth -32.73%
- Total Assets 7.89%
About Hawm Parenteral
Hawm Parenteral Private Limited (HPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 December 2008 and has a history of 16 years and two months. Its registered office is in Srinagar, Jammu & Kashmir, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kamili Ahmed and Masuda Kausa serve as directors at the Company.
Company Details
-
Location
Srinagar, Jammu & Kashmir, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24239JK2008PTC002956
-
Company No.
002956
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Dec 2008
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Jammu
Industry
Who are the key members and board of directors at Hawm Parenteral?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamili Ahmed
|
Director | 18-Dec-2008 | Current |
|
Masuda Kausa
|
Director | 15-Nov-2013 | Current |
Financial Performance of Hawm Parenteral.
Hawm Parenteral Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 160.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 32.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hawm Parenteral?
In 2018, Hawm Parenteral had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Himalayan Rolling Steel Industries Private LimitedKamili Ahmed and Masuda Kausa are mutual person
-
Hawm Life Sciences Private LimitedKamili Ahmed and Masuda Kausa are mutual person
-
Himalayan Transport Company Private Limited
Kamili Ahmed is a mutual person
-
Alfa Trading Company Private Limited
Kamili Ahmed and Masuda Kausa are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hawm Parenteral?
Unlock and access historical data on people associated with Hawm Parenteral, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hawm Parenteral, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hawm Parenteral's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
